Long-term use of spironolactone for acne in women: A case series of 403 patients
- 8 January 2021
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 84 (5), 1348-1355
- https://doi.org/10.1016/j.jaad.2020.12.071
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Foundation
- Pfizer
This publication has 29 references indexed in Scilit:
- Duration of oral antibiotic therapy for the treatment of adult acne: A retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savingsJournal of the American Academy of Dermatology, 2015
- Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgarisJournal of the American Academy of Dermatology, 2014
- A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: Investigating practice gaps and potential cost-savingsJournal of the American Academy of Dermatology, 2014
- The prevalence of acne in adults 20 years and olderJournal of the American Academy of Dermatology, 2008
- Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenoneJournal of the American Academy of Dermatology, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) StatementEpidemiology, 2007
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesPLoS Medicine, 2007
- Anti-androgenic Therapy Using Oral Spironolactone for Acne Vulgaris in AsiansAesthetic Plastic Surgery, 2006
- Long-Term Safety of Spironolactone in Acne: Results of an 8-Year Followup StudyJournal of Cutaneous Medicine and Surgery, 2002
- Low-dose adjunctive spironolactone in the treatment of acne in women: A retrospective analysis of 85 consecutively treated patientsJournal of the American Academy of Dermatology, 2000